RenovoRx (RNXT) EBT (2020 - 2026)

RenovoRx has disclosed EBT across 7 years of filings, most recently posting -$3.3 million for Q2 2026.

• In Q2 2026, EBT fell 28.06% year-over-year to -$3.3 million; the TTM figure through Jun 2026 stood at -$13.2 million (down 22.38% YoY), while the FY2025 annual figure was -$12.1 million, down 14.14% from the prior year.
• EBT came in at -$3.3 million for Q2 2026 at RenovoRx, up from -$3.4 million in the prior quarter.
• In the past five years, EBT ranged from a high of -$1.8 million in Q4 2023 to a low of -$3.4 million in Q4 2025.
• Average EBT over 5 years is -$2.8 million, with a median of -$2.9 million recorded in 2023.
• Year-over-year, EBT tumbled 185.28% in 2022 and gained 25.12% in 2024.
• Over 5 years, EBT stood at -$2.2 million in 2022, then climbed by 18.09% to -$1.8 million in 2023, then tumbled by 44.22% to -$2.5 million in 2024, then plunged by 35.34% to -$3.4 million in 2025, then increased by 5.45% to -$3.3 million in 2026.
• Per Business Quant data, the three most recent EBT figures were -$3.3 million in Q2 2026, -$3.4 million in Q1 2026, and -$3.4 million in Q4 2025.